InvestmentLed ALP Bio AG's $2.2M pre-seed round to de-risk antibody development with immunogenicity intelligence.ALP BioALP Bio42CAPventurekick.chAPR 30, 2026alp.bioAPR 30, 2026
InvestmentParticipated in Qdrant's $50M Series B led by AVP, alongside Spark Capital, Unusual Ventures, and Bosch Ventures.
New FundClosed Fund IV at EUR 100M to continue investing in seed-stage B2B software and AI companies across Europe.Fund IV42CAPypog.lawAPR 2025APR 2025